Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case-Control Study

• Egile Nagusiak: Nawal Farhat (Egilea), Nicholas Birkett (Egilea), Nisrine Haddad (Egilea), Yannick Fortin (Egilea), Franco Momoli (Egilea), Shi Wu Wen (Egilea), Andreas Wielgosz (Egilea), Doug S. McNair (Egilea), Donald R. Mattison (Egilea), Daniel Krewski (Egilea)
• Formatua: Liburua
• Argitaratua: Adis, Springer Healthcare, 2020-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The clinical implications of potential interactions between proton pump inhibitors (PPIs) and clopidogrel have been debated for over a decade. Objective We assessed the association between combined clopidogrel-PPI treatment and the risk of recurrent myocardial infarction (MI) and...